Publications - 'E'
Publications 726 - 750 de 2582
| Titre | DOI |
|---|---|
|
Efficacy and Pharmacokinetics Evaluation of a Single Oral Dose of Afoxolaner against Sarcoptes scabiei in the Porcine Scabies Model for Human Infestation C. Bernigaud; F. Fang; K. Fischer; A. Lespine; L.S. Aho; A.J. Mullins; B. Tecle; A. Kelly; J.F. Sutra; F. Moreau; T. Lilin; F. Beugnet; F. Botterel; O. Chosidow; J. Guillot 2018 |
10.1128/AAC.02334-17 |
|
EFFICACY AND SAFETY OF A DISTRACTION-ROTATION KNEE BRACE (ODRA) IN MEDIAL KNEE OSTEOARTHRITIS - A PHASE III RANDOMISED CONTROLLED TRIAL (ERGONOMIE STUDY) A. Diaz; C. Morisset; I. Fournel; A.L. Soilly; C. Bussiere; A. Cherasse; T. Conrozier; D. Loeuille; M. Timsit; D. Wendling; J.M. Casillas; J.F. Maillefert; C. Binquet; P. Ornetti 2018 |
10.1136/annrheumdis-2018-eular.4927 |
|
Efficacy and safety of a recombinant Von Willebrand Factor treatment in patients with inherited Von Willebrand Disease requiring surgical procedures D. Desprez; N. Drillaud; C. Flaujac; F. Volot; B. Pan-Petesch; P. Beurrier; V. Cussac; O. Feugeas; Y. Pailler; A. Callegarin; M. Trossaert; E. de Raucourt 2021 |
10.1111/hae.14242 |
|
EFFICACY AND SAFETY OF A RECOMBINANT VON WILLEBRAND FACTOR TREATMENT IN PATIENTS WITH INHERITED VON WILLEBRAND DISEASE REQUIRING SURGICAL PROCEDURES: A FRENCH MULTICENTRE RETROSPECTIVE STUDY D. Desprez; N. Drillaud; C. Flaujac; F. Volot; B. Pan-Petesch; P. Beurrier; V. Cussac; O. Feugeas; Y. Pailler; A. Callegarin; M. Trossaert; E. De Raucourt 2021 |
|
|
EFFICACY AND SAFETY OF A RECOMBINANT VON WILLEBRAND FACTOR TREATMENT IN PATIENTS WITH INHERITED VON WILLEBRAND DISEASE REQUIRING SURGICAL PROCEDURES: A FRENCH MULTICENTRE RETROSPECTIVE STUDY D. Desprez; N. Drillaud; C. Flaujac; F. Volot; B. Pan-Petesch; P. Beurrier; V. Cussac; O. Feugeas; Y. Pailler; A. Callegarin; M. Trossaert; E. De Raucourt 2021 |
|
|
Efficacy and Safety of Aflibercept in Combination With Chemotherapy Beyond Second-Line Therapy in Metastatic Colorectal Carcinoma Patients: An AGEO Multicenter Study M. Auvray; D. Tougeron; E. Auclin; V. Moulin; P. Artru; V. Hautefeuille; P. Hammel; T. Lecomte; C. Locher; G. Sickersen; R. Coriat; C. Lecaille; D. Vernerey; J. Taieb; S. Pernot 2020 |
10.1016/j.clcc.2019.08.003 |
|
Efficacy and safety of alemtuzumab in 104 patients with active relapsing- remitting MS: one-year follow-up in France X. Ayrignac; N. Collongues; J. De Seze; P. Vermersch; D. Biotti; D. Brassat; C. Carra-Dalliere; S. Vukusic; F. Durand-Dubief; G. Edan; E. Lepage; V. Deburghgraeve; E. Maillart; C. Papeix; P. Alla; E. Berger; B. Bourre; O. Casez; S. Pittion; M. Debouverie; M. Theaudin; N. Derache; G. Defer; O. Gout; R. Deschamps; A. Tourbah; F. Zagnoli; A. Ruet; J.C. Ouallet; B. Brochet; E. Manchon; T. Moreau; A. Fromont; P. Clavelou; F. Taithe; A.M. Guennoc; J.P. Camdessanche; A. Carpentier; I. Coman; B. Audoin; J. Pelletier; A. Rico; L. Magy; J. Ciron; S. Wiertlewski; D. Laplaud; T. de Broucker; C. Lebrun; M. Cohen; P. Labauge; C.Francophon Plaques; S.Francophon Plaques 2016 |
|
|
Efficacy and safety of alemtuzumab in 113 patients with active relapsing-remitting MS: one-year follow-up in France X. Ayrignac; N. Collongues; J. de Seze; P. Vermersch; D. Biotti; D. Brassat; S. Vukusic; F. Durand-Dubief; G. Edan; E. LePage; V. Deburghgraeve; E. Maillart; C. Papeix; P. Alla; E. Berger; B. Bourre; O. Casez; S. Pittion; M. Debouverie; M. Theaudin; N. Derache; G. Defer; O. Gout; R. Deschamps; A. Tourbah; F. Zagnoli; A. Ruet; J. Ouallet; B. Brochet; E. Manchon; T. Moreau; A. Fromont; P. Clavelou; A.Marie Guennoc; J.P. Camdessanche; A. Carpentier; I.Antoanela Coman; B. Audoin; J. Pelletier; L. Magy; J. Ciron; S. Wiertlevski; D. Laplaud; T. De Broucker; C.Lebrun Frenay; M. Cohen; P. Labauge 2017 |
|
|
Efficacy and safety of alemtuzumab in 113 patients with active relapsing-remitting MS: one-year follow-up in France X. Ayrignac; N. Collongues; J. de Seze; P. Vermersch; D. Biotti; D. Brassat; S. Vukusic; F. Durand-Dubief; G. Edan; E. LePage; V. Deburghgraeve; E. Maillart; C. Papeix; P. Alla; E. Berger; B. Bourre; O. Casez; S. Pittion; M. Debouverie; M. Theaudin; N. Derache; G. Defer; O. Gout; R. Deschamps; A. Tourbah; F. Zagnoli; A. Ruet; J. Ouallet; B. Brochet; E. Manchon; T. Moreau; A. Fromont; P. Clavelou; A.Marie Guennoc; J.P. Camdessanche; A. Carpentier; I.Antoanela Coman; B. Audoin; J. Pelletier; L. Magy; J. Ciron; S. Wiertlevski; D. Laplaud; T. De Broucker; C.Lebrun Frenay; M. Cohen; P. Labauge 2017 |
|
|
Efficacy and safety of alemtuzumab in 150 patients with active relapsing-remitting MS: two-year follow-up in France X. Ayrignac; N. Collongues; J. De Seze; P. Vermersch; D. Brassat; D. Biotti; C. Carra-Dalliere; M. Charif; S. Vukusic; F. Durand-Dubief; G. Edan; E. Lepage; V. Deburghgraeve; E. Maillart; C. Papeix; P. Alla; E. Berger; B. Bourre; O. Casez; S. Pittion; M. Debouverie; N. Derache; G. Defer; O. Gout; R. Deschamps; A. Tourbah; F. Zagnoli; A. Ruet; J.C. Ouallet; B. Brochet; E. Manchon; T. Moreau; A. Fromont; P. Clavelou; A.M. Guennoc; J.P. Camdessanche; A. Carpentier; I. Coman; B. Audoin; J. Pelletier; L. Magy; S. Wiertlewski; D. Laplaud; J. Ciron; T. de Broucker; L. Frenay; M. Cohen; P. Labauge; C.Francophon Plaques; S.Francophon Plaques; OFSEP 2017 |
|
|
Efficacy and safety of alemtuzumab in 150 patients with active relapsing-remitting MS: two-year follow-up in France X. Ayrignac; N. Collongues; J. De Seze; P. Vermersch; D. Brassat; D. Biotti; C. Carra-Dalliere; M. Charif; S. Vukusic; F. Durand-Dubief; G. Edan; E. Lepage; V. Deburghgraeve; E. Maillart; C. Papeix; P. Alla; E. Berger; B. Bourre; O. Casez; S. Pittion; M. Debouverie; N. Derache; G. Defer; O. Gout; R. Deschamps; A. Tourbah; F. Zagnoli; A. Ruet; J.C. Ouallet; B. Brochet; E. Manchon; T. Moreau; A. Fromont; P. Clavelou; A.M. Guennoc; J.P. Camdessanche; A. Carpentier; I. Coman; B. Audoin; J. Pelletier; L. Magy; S. Wiertlewski; D. Laplaud; J. Ciron; T. de Broucker; L. Frenay; M. Cohen; P. Labauge; C.Francophon Plaques; S.Francophon Plaques; OFSEP 2017 |
|
|
Efficacy and Safety of Alirocumab in Individuals with Diabetes Mellitus: Pooled Analyses from Five Placebo-Controlled Phase 3 Studies H.N. Ginsberg; M. Farnier; J.G. Robinson; C.P. Cannon; N. Sattar; M.T. Baccara-Dinet; A. Letierce; M. Bujas-Bobanovic; M.J. Louie; H.M. Colhoun 2018 |
10.1007/s13300-018-0439-8 |
|
Efficacy and safety of an innovative prolonged-release combination drug in patients with distal renal tubular acidosis: an open-label comparative trial versus standard of care treatments A. Bertholet-thomas; C. Guittet; M.A. Manso-Silvan; A. Castang; V. Baudouin; M. Cailliez; M. Di Maio; O. Gillion-boyer; E. Golubovic; J. Harambat; A. Klein; B. Knebelmann; F. Nobili; R. Novo; L. Podracka; G. Roussey-Kesler; C. Stylianou; Landre Granier 2021 |
10.1007/s00467-020-04693-2 |
|
Efficacy and safety of anti TNF alpha in non-infectious uveitis: a multi-center retrospective study B. Garnier; H. Vallet; P. Seve; E. Heron; A. Perlat; N. Tieulie; L. Perard; P. Lehoang; D. Saadoun; B. Bodaghi 2014 |
|
|
Efficacy and safety of anti TNF alpha in non-infectious uveitis: a multi-center retrospective study B. Garnier; H. Vallet; P. Seve; E. Heron; A. Perlat; N. Tieulie; L. Perard; P. Lehoang; D. Saadoun; B. Bodaghi 2014 |
|
|
Efficacy and Safety of ANTI-TNF ALPHA in BEHCET Disease: A International Multicenter Registry of 122 Patients. H. Vallet; S. Riviere; A. Deroux; G. Moulis; O. Addimanda; C. Salvarani; M. Lambert; P. Bielfeld; P. Seve; J. Sibilia; J.Baptiste Fraison; Y. Schoindre; I. Marie; L. Perard; T. Papo; D. Sene; G. Leroux; V. Royant; A. Perlat; X. Mariette; O. Lidove; O. Fain; C. de Moreuil; G. Blaison; P. LE Hoang; E. Hachulla; B. Wechsler; B. Bodaghi; P. Cacoub; D. Saadoun 2014 |
|
|
EFFICACY AND SAFETY OF ANTI-TNF ALPHA IN BEHCET DISEASE: PRELIMINARY RESULTS OF A FRENCH MULTICENTER REGISTRY OF 92 PATIENTS H. Vallet; S. Riviere; M. Lambert; A. Deroux; P. Bielfeld; P. Seve; J.B. Fraison; L. Perard; Y. Schoindre; T. Papo; G. Kaplanski; J. Sellam; T. Le Hoang; O. Fain; I. Marie; D. Sene; X. Mariette; G. Blaison; E. Hachulla; A. Perlat; B. Wechsler; P. Cacoub; B. Bodaghi; D. Saadoun 2014 |
10.1136/annrheumdis-2014-eular.5903 |
|
Efficacy and Safety of Bevacizumab Combined With First-Line Chemotherapy in Elderly (>= 75 Years) Patients With Metastatic Colorectal Cancer: A Real-World Study E. Francois; L. Mineur; G. Deplanque; P. Laplaige; D. Smith; S. Gourgou; A. Tanang; M. Ionescu-Goga; K. Veerabudun; Y. Lelarge; S. Kim; F. Rollot 2020 |
10.1016/j.clcc.2020.02.009 |
|
Efficacy and safety of bevacizumab-containing neoadjuvant therapy followed by interval debulking surgery in advanced ovarian cancer: Results from the ANTHALYA trial R. Rouzier; S. Gouy; F. Selle; E. Lambaudie; A. Floquet; V. Fourchotte; C. Pomel; P.E. Colombo; E. Kalbacher; S. Martin-Francoise; R. Fauvet; P. Follana; A. Lesoin; F. Lecuru; Y. Ghazi; J. Dupin; E. Chereau; S. Zohar; P. Cottu; F. Joly 2017 |
10.1016/j.ejca.2016.09.036 |
|
Efficacy and safety of biologics in relapsing polychondritis: a French national multicentre study G. Moulis; G. Pugnet; N. Costedoat-Chalumeau; A. Mathian; G. Leroux; J. Boutemy; O. Espitia; L. Bouillet; S. Berthier; J.B. Gaultier; P.Y. Jeandel; A. Konate; A. Mekinian; E. Solau-Gervais; B. Terrier; D. Wendling; F. Andry; C. Garnier; P. Cathebras; L. Arnaud; A. Palmaro; P. Cacoub; Z. Amoura; J.C. Piette; P. Arlet; M. Lapeyre-Mestre; L. Sailler 2018 |
10.1136/annrheumdis-2017-212705 |
|
Efficacy and Safety of Biologics in Relapsing Polychondritis: A National Multicenter Study in France G. Moulis; G. Pugnet; N. Costedoat-Chalumeau; A. Mathian; G. Leroux; J. Boutemy; L. Bouillet; S. Berthier; J.Baptiste Gaultier; P.Y. Jeandel; A. Konate; A. Mekinian; E. Solau-Gervais; B. Terrier; D. Wendling; C. Garnier; P. Cathebras; L. Arnaud; P. Cacoub; Z. Amoura; J.C. Piette; P. Arlet; A. Palmaro; M. Lapeyre-Mestre; L. Sailler 2016 |
|
|
Efficacy and safety of dapsone as second line therapy for adult immune thrombocytopenia: A retrospective study of 42 patients C. Esteve; M. Samson; A. Guilhem; B. Nicolas; V. Leguy-Seguin; S. Berthier; B. Bonnotte; S. Audia 2017 |
10.1371/journal.pone.0187296 |
|
Efficacy and safety of defibrotide in the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome following hematopoietic stem cell transplantation: Interim results from the defifrance study M. Mohty; M. Labopin; D. Lebon; A. Berceanu; C. Jubert; I. Yakoub-Agha; S. Girault; M. Detrait; C. Pochon; F. Rialland; V. Gandemer; R.Peffault de Latour; D. Michonneau; F. Delaval; G. Michel; A. Sirvent; L. Clement; A.L. Menard; A. Huynh; V. Bouvatier; R. Hanvesakul; Z. Medeghri; J.H. Dalle 2019 |
|
|
Efficacy and safety of direct oral anticoagulants in intermediate-high risk pulmonary embolism: results from a multidisciplinary multicenter prospective registry R. Chopard; J.N. Andarelli; S. Humbert; N. Falvo; M. Morel-Aleton; B. Bonnet; G. Napporn; E. Kalbacher; L. Obert; B. Degano; G. Capellier; Y. Cottin; F. Schiele; N. Meneveau 2018 |
|
|
Efficacy and safety of direct oral anticoagulants in intermediate-high risk pulmonary embolism: results from a multidisciplinary multicenter prospective registry R. Chopard; J.N. Andarelli; S. Humbert; N. Falvo; M. Morel-Aleton; B. Bonnet; G. Napporn; E. Kalbacher; L. Obert; B. Degano; G. Capellier; Y. Cottin; F. Schiele; N. Meneveau 2018 |